|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to cash provided by operating activities | |||||
| Share-based compensation expense | |||||
| Depreciation and amortization (including amounts in cost of revenue) | |||||
| Amortization of deferred financing costs and debt discount | |||||
| Net loss on extinguishment or repurchase of debt | |||||
| Loss from equity investees | |||||
| Gain on sale of investments and step-up of equity method investments | |||||
| Realized and unrealized losses (gains) on investments | |||||
| Gains on lease modifications | |||||
| (Gains) losses on investments | |||||
| Asset impairment expense | |||||
| Deferred income tax (benefit) expense | |||||
| Other operating activities, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Other current assets | |||||
| Inventory | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Contract liabilities | |||||
| Other current liabilities | |||||
| Other liabilities | |||||
| Cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property, plant and equipment | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Proceeds from the sale of investments | |||||
| Loans to equity method investee | |||||
| Purchase of investments | |||||
| Proceeds from sale of equity method investments | |||||
| Proceeds from sale of investments | |||||
| Cash paid for asset acquisitions | |||||
| Other investing activities | |||||
| Cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from rights offering and private placement, net of issuance costs | |||||
| Proceeds from lines of credit, net of deferred financing costs | |||||
| Payments on lines of credit | |||||
| Principal payments on other debt obligations | |||||
| Proceeds from other debt obligations, net of deferred financing costs | |||||
| Principal payments for and repurchases of other debt obligations | |||||
| Purchase of preferred stock | |||||
| Payments to non-controlling interests and redeemable non-controlling interests related to sale of equity method investment | |||||
| Deferred financing costs paid to third parties | |||||
| Payments to non-controlling interests related to former sale of equity method investment | |||||
| Dividend payments | |||||
| Other financing activities | |||||
| Cash used in financing activities | |||||
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash and cash equivalents, including restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
Loading...